PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.36%
Revenue growth above 1.5x ON's 5.21%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
15.92%
Gross profit growth above 1.5x ON's 6.75%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
75.90%
Positive EBIT growth while ON is negative. John Neff might see a substantial edge in operational management.
75.90%
Positive operating income growth while ON is negative. John Neff might view this as a competitive edge in operations.
14.77%
Positive net income growth while ON is negative. John Neff might see a big relative performance advantage.
-15.38%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-16.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
50.74%
Share change of 50.74% while ON is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
51.98%
Diluted share change of 51.98% while ON is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-35.45%
Dividend reduction while ON stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
109.22%
OCF growth under 50% of ON's 2216.67%. Michael Burry might suspect questionable revenue recognition or rising costs.
186.64%
FCF growth 1.25-1.5x ON's 160.51%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
-48.19%
Negative 10Y revenue/share CAGR while ON stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
21.71%
5Y CAGR of 21.71% while ON is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
-38.73%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
36.94%
OCF/share CAGR of 36.94% while ON is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
120.38%
OCF/share CAGR of 120.38% while ON is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
8.97%
Positive 3Y OCF/share CAGR while ON is negative. John Neff might see a big short-term edge in operational efficiency.
71.28%
10Y net income/share CAGR of 71.28% while ON is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
137.70%
Net income/share CAGR of 137.70% while ON is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
-45.79%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
127.57%
Equity/share CAGR of 127.57% while ON is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
59.18%
Equity/share CAGR of 59.18% while ON is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
-36.96%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-5.96%
Cut dividends over 10 years while ON stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-4.47%
Negative 5Y dividend/share CAGR while ON stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-34.92%
Negative near-term dividend growth while ON invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-4.66%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-1.11%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.81%
Positive asset growth while ON is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-31.13%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.48%
We’re deleveraging while ON stands at 0.77%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-4.27%
Our R&D shrinks while ON invests at 106.02%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.60%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.